4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-044060
EVP, Research & CSO sold 7,900 shares at $47.99 ($379,090)
- EVP, Research & CSO acquired 7,900 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-07-28 | Option exercise | +7,900 | $1.53 | $12,087 | 7,900 | D |
| Virgin Herbert EVP, Research & CSO | 2020-07-28 | Sale | −7,900 | $47.99 | $379,090 | 0 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2020-07-28 | Option exercise · Stock Option (Right to Buy) | −7,900 | 508,155 | D | ||
| Open-market sales · 7,900 sh · avg $47.99 · $379,090 | |||||||
Loading xslF345X03/doc4.xml…